This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: BioCryst (BCRX), Zymeworks (ZYME)

Tipranks - Tipranks - Wed Jul 1, 7:34AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioCryst (BCRX) and Zymeworks (ZYME) with bullish sentiments.

End of Quarter Sale - 70% Off

BioCryst (BCRX)

In a report released today, Laura Chico from Wedbush maintained a Buy rating on BioCryst, with a price target of $21.00. The company’s shares closed last Monday at $9.55.

According to TipRanks.com, Chico is a 5-star analyst with an average return of 14.6% and a 54.3% success rate. Chico covers the Healthcare sector, focusing on stocks such as Praxis Precision Medicines, Ultragenyx Pharmaceutical, and Sionna Therapeutics, Inc. ;'>

BioCryst has an analyst consensus of Strong Buy, with a price target consensus of $24.14, implying a 144.1% upside from current levels. In a report released yesterday, Cantor Fitzgerald also maintained a Buy rating on the stock with a $29.00 price target.

See today’s best-performing stocks on TipRanks >>

Zymeworks (ZYME)

Truist Financial analyst Gregory Renza maintained a Buy rating on Zymeworks today. The company’s shares closed last Monday at $24.10.

According to TipRanks.com, Renza is a 5-star analyst with an average return of 18.2% and a 50.9% success rate. Renza covers the Healthcare sector, focusing on stocks such as Ascentage Pharma Group International Unsponsored ADR, Perspective Therapeutics, and Abivax SA Sponsored ADR. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Zymeworks with a $38.17 average price target, a 64.5% upside from current levels. In a report issued on June 28, Stifel Nicolaus also maintained a Buy rating on the stock.

Read More on BCRX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).